Publications

The Public Health and Chronic Disease Grant program started on 1 July 2016. These guidelines outline the types of activities that this program funds, and how they are administered.

This report outlines an analysis of the psychiatry workforce and the results of updated supply and demand projections, as well as considering capacity and distribution for vocational training into the future. It is part of our series on Australia’s Future Health Workforce.

This fact sheet contains the list of security sensitive biological agents (SSBAs) that we regulate in Australia.

This document sets out the principles that proposals had to address when applying for Pharmacy Trial Program grants.

This guideline explains to entities, facilities and individuals their obligations for security sensitive biological agents (SSBAs) occurring in the natural environment. These SSBAs are not intended to be regulated under the SSBA Regulatory Scheme.

These guidelines for Public Health Units provide nationally consistent guidance on how to respond to psittacosis. They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).

The National Oral Health Plan 2015–2024 has 2 national goals. Firstly, to improve the oral health status of Australians by reducing the incidence, prevalence and effects of oral disease. And secondly to reduce inequalities in oral health status across the Australian population.

These guidelines outline how the Primary Health Networks (PHN) program and its funding arrangements work, as well as the responsibilities of funded PHNs.

These 10 simple tips will help you establish and maintain an effective administrative record keeping system.

This template is intended to assist practices develop a customised Medicare billing assurance manual. It contains examples of policy statements and operational guidance.

Encourage health professionals in your practice to complete this questionnaire after undertaking a Medicare billing assurance review. You can use the responses to track perceptions and attitudes in your practice and identity areas to focus on.

Encourage health professionals in your practice to complete the following questionnaire before undertaking a Medicare billing assurance review of your practice. You can track perceptions and attitudes and identity trends to focus on.

This Medicare billing assurance charter sets out the principles that support billing activities under Medicare. Your practice should consider adopting this Charter as part of its Medicare billing assurance approach.

This template helps practices develop a Medicare billing assurance manual. The manual can be customised to suit the particular requirements of each practice. It contains examples of policy statements and operational guidance which can create a Medicare billing assurance approach.

The 5 Steps in the Toolkit make up a continuous improvement cycle for your practice’s Medicare billing assurance approach.

This guideline outlines what you can do to substantiate that an individual had a specified condition before the service is eligible. This relates to Medicare Benefits Schedule (MBS) items 11823, 18350 and 30511.

This guideline outlines what you can do to substantiate diagnostic imaging and pathology services rendered to emergency department patients of public hospitals and claimed under Medicare.

This guideline outlines what you can do to substantiate histopathological proof of malignancy for Medicare Benefits Schedule (MBS) items 30196, 30197, 30202, 30203 and 30205.

This guideline outlines what you can do to substantiate that a patient attended a service and relates to Medicare Benefits Schedule (MBS) items such as 23, 36, 104, 5020, 10960 and 8553 that require the patient to be present.

This guideline outlines what you can do to substantiate that a specific treatment or action was performed as part of the requirements for Medicare Benefits Schedule (MBS) items e.g. 10960, 13757, 30189, 47600 and 85533.

This document outlines the processes for Primary Health Networks (PHNs) to follow in conducting a needs assessment.

This document contains the surveillance case definition for Barmah Forest virus infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for cryptosporidiosis, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for rotavirus, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for shigellosis, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.